基线脂蛋白(a)对接受奥氮平治疗的患者发生血脂异常风险的预测价值

Read full text Summarise with VIRAT
Authors: 黄志强, 张嘉萱, 李维娜, 杨建明, 王文永
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

目的探讨基线脂蛋白(a)[Lipoprotein(a),Lp(a)]水平对接受奥氮平治疗的患者发生血脂异常风险的预测价值。方法对183例接受奥氮平治疗的住院患者进行一项为期4个月的回顾性队列研究。将基线Lp(a)作为连续变量或按四分位数分组,采用多因素Cox比例风险回归模型评估基线Lp(a)水平与血脂异常发生风险的关系。结果多因素Cox比例风险回归模型分析结果显示,在完全校正模型中,基线Lp(a)水平作为连续变量与血脂异常发生风险显著相关,基线Lp(a)水平每升高100 mg/L,血脂异常风险增加13.6%(HR=1.136,95%CI 1.039~1.242,P=0.005)。将患者按基线Lp(a)水平的四分位分为4组,与最低四分位Q1组相比,最高四分位Q4组发生血脂异常的风险增加97.2%(HR=1.972,95%CI 1.156~3.363,P=0.013)。血脂异常累积发生率曲线显示:Q4组的累积血脂异常发生率显著高于其他3组(P

Fields of Study & Subjects

Schizophrenia research and treatment Lipoproteins and Cardiovascular Health Pharmacogenetics and Drug Metabolism

Publication details

Journal / source
DOAJ (DOAJ: Directory of Open Access Journals)
Publication date
1 March 2026
Language
ZH